431 reports of this reaction
6.5% of all OMEPRAZOLE AND SODIUM BICARBONATE reports
#3 most reported adverse reaction
RENAL FAILURE is the #3 most commonly reported adverse reaction for OMEPRAZOLE AND SODIUM BICARBONATE, manufactured by Santarus, Inc... There are 431 FDA adverse event reports linking OMEPRAZOLE AND SODIUM BICARBONATE to RENAL FAILURE. This represents approximately 6.5% of all 6,647 adverse event reports for this drug.
Patients taking OMEPRAZOLE AND SODIUM BICARBONATE who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL FAILURE is moderately reported among OMEPRAZOLE AND SODIUM BICARBONATE users, representing a notable but not dominant share of adverse events.
In addition to renal failure, the following adverse reactions have been reported for OMEPRAZOLE AND SODIUM BICARBONATE:
The following drugs have also been linked to renal failure in FDA adverse event reports:
RENAL FAILURE has been reported as an adverse event in 431 FDA reports for OMEPRAZOLE AND SODIUM BICARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL FAILURE accounts for approximately 6.5% of all adverse event reports for OMEPRAZOLE AND SODIUM BICARBONATE, making it one of the most commonly reported side effect.
If you experience renal failure while taking OMEPRAZOLE AND SODIUM BICARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.